COMPANY NEWS


Marksans Pharma Ltd
BSE Code 524404 ISIN Demat INE750C01026 Book Value (₹) 25.68 NSE Symbol MARKSANS Div & Yield % 0.3 Market Cap ( Cr.) 7,558.77 P/E * 63.66 EPS * 2.62 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Marksans Pharma arm receives EIR from USFDA Back
(03 Nov 2023)
Marksans Pharma announced that its wholly owned subsidiary Time-Cap Laboratories, Inc. has received Establishment Inspection Report (ErR) from US Food & Drugs Administration for the audit conducted in October 2023. No 483' s were issued during the Audit.